Osiris Therapeutics, Inc. (OSIR) Release: Swissmedic Invokes Rapid Authorization Procedures for Prochymal Review
9/28/2012 10:25:38 AM
More...
|
Apricus Biosciences (APRI) Submits Response to Swissmedic for Its Vitaros(R) Market Application for Erectile Dysfunction
6/14/2012 9:48:19 AM
More...
|
Celgene International Sárl (CELG)'s REVLIMID(R) Granted Swissmedic Approval for Treatment of Rare Blood Cancer
11/21/2011 7:25:20 AM
More...
|
Swissmedic Grants Approval for a Clinical Study of Neovacs SA's TNFa-kinoid Candidate for the Treatment of Crohn's Disease
6/2/2009 3:27:41 PM
More...
|
Manhattan Pharmaceuticals, Inc. (MHTT) Receives Swissmedic's Approval To Commence Phase IIa Trial With OE, Its Oral Obesity Drug Candidate
5/16/2006 12:40:11 PM
More...
|
Manhattan Pharmaceuticals, Inc. (MHTP) Receives Swissmedic's Approval For Initiation Of Human Safety Trials For Oleoyl Estrone
10/19/2005 5:12:30 PM
More...
|
ImClone (IMCL) Issues Statement Regarding Swissmedic Pre-Notification Of Marketing Authorization For ERBITUX(TM)
10/19/2005 5:10:46 PM
More...
|